Urantoin en es it fr

Categoria

Urantoin Marchi, Urantoin Analoghi

Urantoin Marchi miscela

  • No information avaliable
  • Urantoin Formula chimica

    C8H6N4O5

    Urantoin RX link

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Urantoin FDA foglio

    Urantoin DMS (foglio di materiale di sicurezza)

    Urantoin MSDS

    Urantoin Sintesi di riferimento

    Nessuna informazione disponibile

    Urantoin Peso molecolare

    238.157 g/mol

    Urantoin Temperatura di fusione

    263 oC

    Urantoin H2O Solubilita

    79,5 mg / L

    Urantoin Stato

    Solid

    Urantoin LogP

    -0.04

    Urantoin Forme di dosaggio

    Compressa

    Urantoin Indicazione

    Per il trattamento delle infezioni del tratto urinario

    Urantoin Farmacologia

    Nitrofurantoina, un agente antibatterico nitrofurano, รจ disponibile in forma microcristallina e macrocrystalline nel trattamento delle infezioni del tratto urinario causata da molti batteri gram-negativi e alcuni batteri gram-positivi.

    Urantoin Assorbimento

    Nessuna informazione disponibile

    Urantoin Tossicita

    Nessuna informazione disponibile

    Urantoin Informazioni paziente

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Urantoin Atto interessato organismi

    Gram negativi e alcuni batteri gram-positivi